We are live on
!
Find out more
MAP
Moody Aldrich Partners Portfolio holdings
AUM
$557M
1-Year Est. Return
122.79%
This Fund
S&P 500
This Quarter
Est. Return
+8.08%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$391M
AUM Growth
+$35.1M
(+9.8%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
23.74%
Holding
136
New
34
Increased
67
Reduced
19
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Southwest Gas
SWX
|
+$5.64M |
| 2 |
SJI
South Jersey Industries, Inc.
SJI
|
+$4.51M |
| 3 |
eHealth
EHTH
|
+$3.9M |
| 4 |
Exponent
EXPO
|
+$3.66M |
| 5 |
FIVE9
FIVN
|
+$3.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Euronet Worldwide
EEFT
|
+$8.94M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
+$4.49M |
| 3 |
COUP
Coupa Software Incorporated
COUP
|
+$4.33M |
| 4 |
HubSpot
HUBS
|
+$4.07M |
| 5 |
INXN
Interxion Holding N.V.
INXN
|
+$3.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.2% |
| 2 | Financials | 13.76% |
| 3 | Technology | 13.4% |
| 4 | Healthcare | 13.37% |
| 5 | Consumer Discretionary | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
76
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.93M | 0.49% |
18,760
+5,619
| +43% | +$437K |
|
77
Ligand Pharmaceuticals
LGND
$5.88B
| $1.9M | 0.49% |
26,692
+1,054
| +4% | +$77.6K |
|
78
CareDx
CDNA
$2.42B
| $1.9M | 0.49% |
52,732
+1,415
| +3% | +$45.3K |
|
79
Axsome Therapeutics
AXSM
$10.9B
| $1.84M | 0.47% |
+71,575
| New | +$1.43M |
|
80
CRISPR Therapeutics
CRSP
$5.17B
| $1.84M | 0.47% |
+39,017
| New | +$1.56M |
|
|
MDCO
81
DELISTED
Medicines Co
MDCO
| $1.84M | 0.47% |
+50,338
| New | +$1.64M |
|
|
HZNP
82
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.56M | 0.4% |
+65,034
| New | +$1.65M |
|
83
Natera
NTRA
$46.1B
| $1.39M | 0.36% |
50,491
+7,286
| +17% | +$161K |
|
|
RARX
84
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $1.23M | 0.32% |
41,039
+1,134
| +3% | +$26K |
|
85
Ally Financial
ALLY
$13.3B
| $1.21M | 0.31% |
38,994
+31,016
| +389% | +$915K |
|
86
Franklin Resources
BEN
$17.2B
| $1.18M | 0.3% |
+33,930
| New | +$1.15M |
|
87
Kohl's
KSS
$2.19B
| $1.11M | 0.28% |
23,327
+20,331
| +679% | +$1.23M |
|
|
NVRO
88
DELISTED
NEVRO CORP.
NVRO
| $1.04M | 0.26% |
15,981
+456
| +3% | +$28.4K |
|
|
BHVN
89
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.01M | 0.26% |
+23,053
| New | +$1.3M |
|
90
Acadia Pharmaceuticals
ACAD
$5.03B
| $902K | 0.23% |
33,746
-26,263
| -44% | -$671K |
|
91
AllianceBernstein
AB
$3.47B
| $849K | 0.22% |
+28,567
| New | +$829K |
|
92
LyondellBasell Industries
LYB
$19.2B
| $810K | 0.21% |
+9,403
| New | +$802K |
|
|
PS
93
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $809K | 0.21% |
+26,668
| New | +$856K |
|
94
Alliance Resource Partners
ARLP
$3.17B
| $752K | 0.19% |
44,307
+34,383
| +346% | +$625K |
|
95
Assured Guaranty
AGO
$3.34B
| $724K | 0.19% |
+17,216
| New | +$759K |
|
96
Capital One
COF
$134B
| $594K | 0.15% |
+6,551
| New | +$586K |
|
97
Lear
LEA
$8.18B
| $561K | 0.14% |
+4,026
| New | +$565K |
|
|
JNPR
98
DELISTED
Juniper Networks
JNPR
| $545K | 0.14% |
+20,458
| New | +$547K |
|
99
Park Hotels & Resorts
PK
$2.97B
| $537K | 0.14% |
+19,481
| New | +$584K |
|
100
Lazard
LAZ
$4.31B
| $486K | 0.12% |
+14,121
| New | +$506K |
|
Similar funds
CAM
QL
TCM
CFP
TC
DIM
NCA
CA
Moody Aldrich Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Moody Aldrich Partners held 136 positions worth $391M, up 9.8% from $356M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Moody Aldrich Partners deployed $15.7M of net new capital in Q2 2019, opening 34 new positions and adding to 67 existing holdings. Its largest new stake was South Jersey Industries, Inc.: 139,468 shares worth $4.7M.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was LHC Group LLC, an estimated $4.49M trimmed.
- Moody Aldrich Partners's largest Q2 2019 buy was South Jersey Industries, Inc.: 139,468 shares worth $4.7M.
- Moody Aldrich Partners added most to Southwest Gas in Q2 2019, an estimated $5.64M increase.
- Moody Aldrich Partners's biggest Q2 2019 reduction was LHC Group LLC, cutting an estimated $4.49M.
- Moody Aldrich Partners fully exited Euronet Worldwide in Q2 2019, selling an estimated $8.94M.
- Moody Aldrich Partners's ten largest holdings make up 24% of its $391M portfolio in Q2 2019.
- Moody Aldrich Partners opened 34 new positions and closed 16 in Q2 2019.
- Moody Aldrich Partners's portfolio value rose 9.8% quarter-over-quarter to $391M.
Based on Moody Aldrich Partners's 13F filing for Q2 2019, filed 26 Jul 2019.